Your browser doesn't support javascript.
loading
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
Alexander, James L; Moran, Gordon W; Gaya, Daniel R; Raine, Tim; Hart, Ailsa; Kennedy, Nicholas A; Lindsay, James O; MacDonald, Jonathan; Segal, Jonathan P; Sebastian, Shaji; Selinger, Christian P; Parkes, Miles; Smith, Philip J; Dhar, Anjan; Subramanian, Sreedhar; Arasaradnam, Ramesh; Lamb, Christopher A; Ahmad, Tariq; Lees, Charlie W; Dobson, Liz; Wakeman, Ruth; Iqbal, Tariq H; Arnott, Ian; Powell, Nick.
Afiliação
  • Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
  • Moran GW; NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals and The University of Nottingham, Nottingham, UK.
  • Gaya DR; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK; Department of Medicine, University of Glasgow, Glasgow, UK.
  • Raine T; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Hart A; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, St Mark's Hospital, London, UK.
  • Kennedy NA; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter, Exeter, UK.
  • Lindsay JO; Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Department of Gastroenterology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • MacDonald J; Department of Medicine, University of Glasgow, Glasgow, UK; Department of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Segal JP; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.
  • Sebastian S; IBD Unit, Hull University Teaching Hospitals NHS Trust, Hull, UK.
  • Selinger CP; Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Parkes M; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Smith PJ; Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trusts, Liverpool, UK.
  • Dhar A; Department of Gastroenterology, County Durham & Darlington NHS Foundation Trust, Durham, UK.
  • Subramanian S; Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trusts, Liverpool, UK.
  • Arasaradnam R; Department of Gastroenterology, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK.
  • Lamb CA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Ahmad T; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter, Exeter, UK.
  • Lees CW; Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK; Department of Gastroenterology, Western General Hospital, Edinburgh, UK.
  • Dobson L; IBD Registry Limited, London, UK.
  • Wakeman R; Crohn's & Colitis UK, Hatfield, UK.
  • Iqbal TH; Institute of Translational Medicine, University of Birmingham, Birmingham, UK; Department of Gastroenterology, University Hospitals Birmingham, Birmingham, UK.
  • Arnott I; Department of Gastroenterology, Western General Hospital, Edinburgh, UK.
  • Powell N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: nicholas.powell@imperial.ac.uk.
Lancet Gastroenterol Hepatol ; 6(3): 218-224, 2021 03.
Article em En | MEDLINE | ID: mdl-33508241
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Holanda